A BUDGET IMPACT MODEL FOR TIOTROPIUM/OLODATEROL VERSUS FIXED-DOSE COMBINATION TRIPLE THERAPY IN PATIENTS WITH COPD

被引：0
|
作者：
Palli, S. R. [1 ]
Clark, B. [1 ]
机构：
[1] Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE493
引用
收藏
页码：S431 / S431
页数：1
相关论文
共 50 条
  • [1] Safety of tiotropium and olodaterol fixed-dose combination for COPD in patients on β-blockers
    McGarvey, Lorcan
    Buhl, Roland
    Korducki, Lawrence
    Amatto, Valeria C.
    Tetzlaff, Kay
    Bjermer, Leif
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [2] Efficacy of tiotropium and olodaterol fixed-dose combination in patients with COPD on β-blockers
    Derom, Eric
    Korn, Stephanie
    Hamilton, Alan
    Amatto, Valeria C.
    Zhao, Yihua
    Maltais, Francois
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [3] Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the Netherlands
    van Boven, Job F. M.
    Kocks, Janwillem W. H.
    Postma, Maarten J.
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 2191 - 2201
  • [4] Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPD
    François Maltais
    Alan Hamilton
    Florian Voß
    M. Reza Maleki-Yazdi
    [J]. Advances in Therapy, 2019, 36 : 962 - 968
  • [5] Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPD
    Maltais, Francois
    Hamilton, Alan
    Voss, Florian
    Maleki-Yazdi, M. Reza
    [J]. ADVANCES IN THERAPY, 2019, 36 (04) : 962 - 968
  • [6] Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China
    Lan, Ying
    Yang, Nan
    Wang, Yirong
    Yang, Yan
    Xu, Min
    He, Qin
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2093 - 2103
  • [7] Profile of a fixed-dose combination of tiotropium/olodaterol and its potential in the treatment of COPD
    Muruganandan, Sanjeevan
    Jayaram, Lata
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1179 - 1189
  • [8] THE FIXED-DOSE COMBINATION OF TIOTROPIUM plus OLODATEROL HAS A RAPID ONSET OF ACTION IN PATIENTS WITH COPD
    Veale, A.
    Ferguson, G.
    Pizzichini, E.
    Flezar, M.
    Groenke, L.
    Korducki, L.
    [J]. RESPIROLOGY, 2016, 21 : 129 - 129
  • [9] The fixed-dose combination of tiotropium plus olodaterol has a rapid onset of action in patients with COPD
    Ferguson, Gary T.
    Pizzichini, Emilio
    Flezar, Matjaz
    Groenke, Lars
    Korducki, Lawrence
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4)
    Buhl, Roland
    Maltais, Francois
    Abrahams, Roger
    Bjermer, Leif
    Derom, Eric
    Ferguson, Gary
    Flezar, Matjaz
    Hebert, Jacques
    McGarvey, Lorcan
    Pizzichini, Emilio
    Reid, Jim
    Veale, Antony
    Groenke, Lars
    Hamilton, Alan
    Korducki, Lawrence
    Tetzlaff, Kay
    Waitere-Wijker, Stella
    Watz, Henrik
    Bateman, Eric
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (04) : 969 - 979
12345